Cargando…
Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement
PURPOSE: Side effects of the coronavirus disease 2019 (COVID-19) vaccines include pain at the injection site, fatigue, headache, myalgias, arthralgias, chills, and fever, all of which can be early indicators of an increased need for glucocorticoid replacement in patients with adrenal insufficiency....
Autores principales: | Katznelson, Laurence, Gadelha, Mônica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872824/ https://www.ncbi.nlm.nih.gov/pubmed/33564969 http://dx.doi.org/10.1007/s11102-021-01130-x |
Ejemplares similares
-
Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic
por: Almeida, Madson Q., et al.
Publicado: (2020) -
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
por: Isidori, Andrea M, et al.
Publicado: (2020) -
A Pituitary Society update to acromegaly management guidelines
por: Fleseriu, Maria, et al.
Publicado: (2020) -
Hypothalamic-Pituitary Axis Function and Adrenal Insufficiency in COVID-19 Patients
por: Durcan, Emre, et al.
Publicado: (2023) -
Recovery of Adrenal Function in Patients with Glucocorticoids Induced Secondary Adrenal Insufficiency
por: Baek, Jong Ha, et al.
Publicado: (2016)